Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body of Adult Participants With Human Immuno-Deficiency Virus (HIV-1)

CenExcel iResearch LLC /ID# 225526, Decatur

Orlando Immunology Center /ID# 223498, Orlando

Midway Immunology and Research Center /ID# 223500, Ft. Pierce

The Christ Hospital /ID# 224871, Cincinnati

University of Iowa Hospitals and Clinics /ID# 224267, Iowa City

North Texas Infectious Diseases Consultants, P.A /ID# 223236, Dallas

Ruane Clinical Research Group /ID# 224125, Los Angeles

Franco Felizarta, Md /Id# 223815, Bakersfield

Quest Clinical Research /ID# 223347, San Francisco

George Washington University Medical Faculty Associates /ID# 223493, Washington D.C.

St. Joseph Comprehensive Research Institute /ID# 246232, Tampa

Triple O Research Institute /ID# 223460, West Palm Beach

Infinite Clinical Trials - Morrow /ID# 225455, Morrow

Be Well Medical Center /ID# 223381, Berkley

North Shore University Hospital Manhasset /ID# 223343, Manhasset

Central Texas Clinical Research /ID# 223378, Austin

Prism Health North Texas - Oak Cliff Health Center /ID# 223237, Dallas

The Crofoot Research Center, Inc /ID# 223383, Houston

Peter Shalit, M.D. /ID# 224252, Seattle

Ponce Medical School Foundation /ID# 224231, Ponce

Clinical Research Puerto Rico /ID# 223923, San Juan